329 related articles for article (PubMed ID: 27342882)
1. Kawasaki disease: a matter of innate immunity.
Hara T; Nakashima Y; Sakai Y; Nishio H; Motomura Y; Yamasaki S
Clin Exp Immunol; 2016 Nov; 186(2):134-143. PubMed ID: 27342882
[TBL] [Abstract][Full Text] [Related]
2. [Kawasaki disease and innate immunity].
Hara T
Nihon Rinsho; 2014 Sep; 72(9):1542-7. PubMed ID: 25518400
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms.
Kusuda T; Nakashima Y; Murata K; Kanno S; Nishio H; Saito M; Tanaka T; Yamamura K; Sakai Y; Takada H; Miyamoto T; Mizuno Y; Ouchi K; Waki K; Hara T
PLoS One; 2014; 9(11):e113054. PubMed ID: 25411968
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Kawasaki Disease.
Kim KY; Kim DS
Yonsei Med J; 2016 Jan; 57(1):15-21. PubMed ID: 26632378
[TBL] [Abstract][Full Text] [Related]
5. A framework for understanding Kawasaki disease pathogenesis.
Lo MS
Clin Immunol; 2020 May; 214():108385. PubMed ID: 32173601
[TBL] [Abstract][Full Text] [Related]
6. Development of Kawasaki disease in a patient with PFAPA.
Ninomiya T; Takada H; Nagatomo Y; Nanishi E; Nagata H; Yamamura K; Doi T; Ikeda K; Hara T
Pediatr Int; 2013 Dec; 55(6):801-2. PubMed ID: 24330294
[TBL] [Abstract][Full Text] [Related]
7. An update on understanding the pathophysiology in Kawasaki disease: Possible role of immune complexes in coronary artery lesion revisited.
Philip S; Jindal A; Krishna Kumar R
Int J Rheum Dis; 2023 Aug; 26(8):1453-1463. PubMed ID: 37431726
[TBL] [Abstract][Full Text] [Related]
8. Kawasaki Disease: The Role of Immune Complexes Revisited.
Menikou S; Langford PR; Levin M
Front Immunol; 2019; 10():1156. PubMed ID: 31263461
[TBL] [Abstract][Full Text] [Related]
9. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
Yang CA; Huang YL; Chiang BL
J Formos Med Assoc; 2022 Mar; 121(3):623-632. PubMed ID: 34193364
[TBL] [Abstract][Full Text] [Related]
10. Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.
Kaneko K; Akagawa S; Akagawa Y; Kimata T; Tsuji S
Front Immunol; 2020; 11():1616. PubMed ID: 32793240
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki disease: A brief history.
Burns JC; Kushner HI; Bastian JF; Shike H; Shimizu C; Matsubara T; Turner CL
Pediatrics; 2000 Aug; 106(2):E27. PubMed ID: 10920183
[TBL] [Abstract][Full Text] [Related]
12. G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1.
Okabe M; Takarada S; Miyao N; Nakaoka H; Ibuki K; Ozawa S; Watanabe K; Tsuji H; Hashimoto I; Hatasaki K; Hayakawa S; Hamaguchi Y; Hamada M; Ichida F; Hirono K
Pediatr Res; 2022 Aug; 92(2):378-387. PubMed ID: 35292727
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune Aspects of Kawasaki Disease.
Sakurai Y
J Investig Allergol Clin Immunol; 2019; 29(4):251-261. PubMed ID: 30183655
[TBL] [Abstract][Full Text] [Related]
14. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.
Rodó X; Curcoll R; Robinson M; Ballester J; Burns JC; Cayan DR; Lipkin WI; Williams BL; Couto-Rodriguez M; Nakamura Y; Uehara R; Tanimoto H; Morguí JA
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):7952-7. PubMed ID: 24843117
[TBL] [Abstract][Full Text] [Related]
15. Single cell RNA-seq resolution revealed CCR1
Liu X; Luo T; Fan Z; Li J; Zhang Y; Lu G; Lv M; Lin S; Cai Z; Zhang J; Zhou K; Guo J; Hua Y; Zhang Y; Li Y
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166707. PubMed ID: 37001702
[TBL] [Abstract][Full Text] [Related]
16. Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
Nakashima Y; Sakai Y; Mizuno Y; Furuno K; Hirono K; Takatsuki S; Suzuki H; Onouchi Y; Kobayashi T; Tanabe K; Hamase K; Miyamoto T; Aoyagi R; Arita M; Yamamura K; Tanaka T; Nishio H; Takada H; Ohga S; Hara T
Cardiovasc Res; 2021 Jan; 117(1):96-108. PubMed ID: 31782770
[TBL] [Abstract][Full Text] [Related]
17. Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease.
Ueno K; Nomura Y; Morita Y; Kawano Y
Front Immunol; 2021; 12():640315. PubMed ID: 34079539
[TBL] [Abstract][Full Text] [Related]
18. B Cells and Antibodies in Kawasaki Disease.
Lindquist ME; Hicar MD
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013925
[TBL] [Abstract][Full Text] [Related]
19. The up-to-date pathophysiology of Kawasaki disease.
Hara T; Yamamura K; Sakai Y
Clin Transl Immunology; 2021; 10(5):e1284. PubMed ID: 33981434
[TBL] [Abstract][Full Text] [Related]
20. Innate immune responses following Kawasaki disease and toxic shock syndrome.
Chen KYH; Messina N; Germano S; Bonnici R; Freyne B; Cheung M; Goldsmith G; Kollmann TR; Levin M; Burgner D; Curtis N
PLoS One; 2018; 13(2):e0191830. PubMed ID: 29447181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
